Source:http://linkedlifedata.com/resource/pubmed/id/21856935
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2011-9-8
|
pubmed:abstractText |
Fas ligand (FasL) belongs to the TNF family of death ligands, and its binding to the FasR leads to activation of several downstream signaling pathways and proteins, including NF-?B and PI3K/Akt. However, it is not known whether cross-talk exists between NF-?B and PI3K/Akt in the context of FasL signaling. We demonstrate using both human renal epithelial 293T cells and Jurkat T-lymphocyte cells that although FasL activates both Akt and NF-?B, Akt inhibits FasL-dependent NF-?B activity in a reactive oxygen species-dependent manner. Cellular FLICE-inhibitory protein (c-FLIP), an antioxidant and an important component of the death-inducing signaling complex, also represses NF-?B upstream of the regulatory I?B kinase-? protein subunit in the NF-?B signaling pathway, and positive cross-talk exists between Akt and c-FLIP in the context of inhibition of FasL-induced NF-?B activity. The presence of two death effector domains of c-FLIP and S-nitrosylation of its caspase-like domain were found to be important for mediating c-FLIP-dependent downregulation of NF-?B activity. Taken together, our study reveals a novel link between NF-?B and PI3K/Akt and establishes c-FLIP as an important regulator of FasL-mediated cell death.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/CASP8 and FADD-Like Apoptosis...,
http://linkedlifedata.com/resource/pubmed/chemical/CFLAR protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1550-6606
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
187
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3256-66
|
pubmed:meshHeading |
pubmed-meshheading:21856935-Antioxidants,
pubmed-meshheading:21856935-Apoptosis,
pubmed-meshheading:21856935-Blotting, Western,
pubmed-meshheading:21856935-CASP8 and FADD-Like Apoptosis Regulating Protein,
pubmed-meshheading:21856935-Cell Line,
pubmed-meshheading:21856935-Enzyme Activation,
pubmed-meshheading:21856935-Fas Ligand Protein,
pubmed-meshheading:21856935-Humans,
pubmed-meshheading:21856935-NF-kappa B,
pubmed-meshheading:21856935-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:21856935-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:21856935-Signal Transduction
|
pubmed:year |
2011
|
pubmed:articleTitle |
Antioxidant c-FLIP inhibits Fas ligand-induced NF-kappaB activation in a phosphatidylinositol 3-kinase/Akt-dependent manner.
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, Hampton University, Hampton, VA 23668, USA. anand.iyer@hamptonu.edu
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|